BRIEF-Abbvie presents data on eight-week treatment of VIEKIRAX
September 23, 2016 at 04:07 AM EDT
* Two patients experienced post-treatment relapse and one subject discontinued due to noncompliance
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.